0.0800CADMkt Cap: 33.99M CADP/E: —Last update: 2026-05-22
MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-like cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Cana…
Industry Peers
Drug Manufacturers - Specialty & Generic153.28BSEKP/E 169.8
56.23BTRYP/E 26.9
55.91BEURP/E 22.1
33.39BPLNP/E 21.7
13.24BSEKP/E 39.9
13.20BEURP/E 30.1
12.83BTRY—
3.96BUSDP/E 33.6
loading…
Indicators:|
Key Statistics
Company
Market Cap33.99M CAD
Enterprise Value24.14M CAD
Revenue (TTM)43.28M CAD
Gross Profit13.97M CAD
Net Income (TTM)-8.27M CAD
Revenue/Share0.1030 CAD
Last Price0.0800 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees127
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA58504D1006
Valuation
P/E (Trailing)—
P/E (Forward)-8.00
PEG—
EV/EBITDA-3.95
EV/Revenue0.56
P/S0.79
P/B0.96
EPS (TTM)-0.02
EPS (Forward)-0.01
52W Range
—
52W High0.0800 CAD
52W Low0.0800 CAD
Profitability
Gross Margin30.95%
Oper. Margin-10.17%
EBITDA Margin-14.11%
Profit Margin-18.32%
ROE-23.08%
ROA-18.07%
Growth
Revenue Growth-17.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.50M CAD
CapEx (TTM)100.00K CAD
FCF Margin11.28%
FCF Yield14.37%
Net Debt-9.85M CAD
Net Debt/EBITDA1.61
Balance Sheet
Debt/Equity0.01
Current Ratio3.02
Quick Ratio1.93
Book Value/Sh0.0830 CAD
Cash/Share0.0230 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.424.86M
Float385.94M
Insiders11.31%
Institutions0.00%
Short Interest
Short Ratio0.4d
Short % Out.0.05%
Shares Short212.35K
Short (prev mo.)204.07K
Technical
SMA 500.0726 (+10.2%)
SMA 2000.0714 (+12.1%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)13.02K
Avg Vol (10d)226.81K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—